**Question:** Atropine and acetylcholine show the following type of antagonism:

A. Tachyphylaxis
B. Competitive
C. Allosteric
D. Non-competitive

**Correct Answer:** B. Competitive

**Core Concept:**
Antagonism in pharmacology refers to the interaction between two drugs or substances that prevent one from exerting its effect. In this context, we are discussing the interaction between atropine and acetylcholine, which are both neuromodulators involved in the parasympathetic nervous system.

**Why the Correct Answer is Right:**
Atropine is a competitive antagonist, meaning that it competes with acetylcholine for binding to its receptor (muscarinic acetylcholine receptors) in the body. When atropine binds to these receptors, it blocks acetylcholine from binding, thus preventing its effect. This is the basis of competitive antagonism.

**Why Each Wrong Option is Incorrect:**
A. Tachyphylaxis: This refers to a reduction in the effectiveness of a drug over time due to desensitization of the target cell, not to the interaction between two drugs.
C. Allosteric antagonism: This type of antagonism involves a change in the conformation of the receptor protein, which is not the case with atropine and acetylcholine.
D. Non-competitive antagonism: This occurs when an antagonist does not compete with the agonist (in this case, acetylcholine) for receptor binding but instead binds to a different site on the receptor or another site on the receptor protein. Atropine is a competitive antagonist, therefore, this option is incorrect.

**Clinical Pearl:**
Understanding the type of antagonism between drugs is crucial in clinical practice, as it helps determine the effectiveness of treatment strategies and potential drug interactions. In this case, the correct answer (competitive antagonism) is important in understanding how atropine's interaction with acetylcholine can be used therapeutically to block its effects, for example, in cases of excessive cholinergic activity like in myasthenia gravis or in the treatment of bradycardia (slow heart rate) due to excessive parasympathetic activity.